Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis

PLoS One. 2021 Dec 30;16(12):e0261728. doi: 10.1371/journal.pone.0261728. eCollection 2021.

Abstract

Background: Gastric carcinoma (GC) is one of the most common cancer globally. Despite its worldwide decline in incidence and mortality over the past decades, gastric cancer still has a poor prognosis. However, the key regulators driving this process and their exact mechanisms have not been thoroughly studied. This study aimed to identify hub genes to improve the prognostic prediction of GC and construct a messenger RNA-microRNA-long non-coding RNA(mRNA-miRNA-lncRNA) regulatory network.

Methods: The GSE66229 dataset, from the Gene Expression Omnibus (GEO) database, and The Cancer Genome Atlas (TCGA) database were used for the bioinformatic analysis. Differential gene expression analysis methods and Weighted Gene Co-expression Network Analysis (WGCNA) were used to identify a common set of differentially co-expressed genes in GC. The genes were validated using samples from TCGA database and further validation using the online tools GEPIA database and Kaplan-Meier(KM) plotter database. Gene set enrichment analysis(GSEA) was used to identify hub genes related to signaling pathways in GC. The RNAInter database and Cytoscape software were used to construct an mRNA-miRNA-lncRNA network.

Results: A total of 12 genes were identified as the common set of differentially co-expressed genes in GC. After verification of these genes, 3 hub genes, namely CTHRC1, FNDC1, and INHBA, were found to be upregulated in tumor and associated with poor GC patient survival. In addition, an mRNA-miRNA-lncRNA regulatory network was established, which included 12 lncRNAs, 5 miRNAs, and the 3 hub genes.

Conclusions: In summary, the identification of these hub genes and the establishment of the mRNA-miRNA-lncRNA regulatory network provide new insights into the underlying mechanisms of gastric carcinogenesis. In addition, the identified hub genes, CTHRC1, FNDC1, and INHBA, may serve as novel prognostic biomarkers and therapeutic targets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Carcinoma / genetics*
  • Computational Biology / methods
  • Extracellular Matrix Proteins / genetics
  • Extracellular Matrix Proteins / metabolism
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Gene Regulatory Networks
  • Genetic Predisposition to Disease
  • Genome, Human
  • Humans
  • Inhibin-beta Subunits / genetics
  • Kaplan-Meier Estimate
  • MicroRNAs / metabolism*
  • Neoplasm Proteins / genetics
  • Prognosis
  • Protein Interaction Maps
  • RNA, Long Noncoding*
  • RNA, Messenger / metabolism*
  • Stomach Neoplasms / genetics*
  • Treatment Outcome
  • Up-Regulation

Substances

  • CTHRC1 protein, human
  • Extracellular Matrix Proteins
  • FNDC1 protein, human
  • MicroRNAs
  • Neoplasm Proteins
  • RNA, Long Noncoding
  • RNA, Messenger
  • inhibin beta A subunit
  • Inhibin-beta Subunits

Grants and funding

This research was supported by the National Natural Science Foundation of China (No. U1604175), Central Leading Local Science and Technology Development Special Foundation (ZYYD2020000169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.